Helen Sabzevari
Chief Executive Officer chez PRECIGEN, INC.
Fortune : 3 M $ au 31/03/2024
Postes actifs de Helen Sabzevari
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PRECIGEN, INC. | Director/Board Member | 19/06/2020 | - |
| Chief Executive Officer | 01/01/2020 | - | |
| President | 01/01/2020 | - | |
PGEN Therapeutics, Inc.
 PGEN Therapeutics, Inc. BiotechnologyHealth Technology Part of Precigen, Inc., PGEN Therapeutics, Inc. develops gene and cellular therapies. The private company is based in Henrico, MD. | President | 01/11/2017 | - |
| Chief Tech/Sci/R&D Officer | 01/06/2017 | 01/11/2017 |
Historique de carrière de Helen Sabzevari
Anciens postes connus de Helen Sabzevari
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KINNATE BIOPHARMA INC. | Director/Board Member | 24/06/2021 | 03/04/2024 |
| Independent Dir/Board Member | 24/06/2021 | 03/04/2024 | |
| PRECIGEN, INC. | Corporate Officer/Principal | 29/06/2017 | 01/11/2017 |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/01/2015 | 01/01/2017 |
| Founder | 01/01/2015 | 01/01/2017 | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Chief Tech/Sci/R&D Officer | 01/01/2008 | 01/01/2014 |
Formation de Helen Sabzevari
| The Scripps Research Institute | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| President | 2 |
| Director/Board Member | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
PGEN Therapeutics, Inc.
PGEN Therapeutics, Inc. BiotechnologyHealth Technology Part of Precigen, Inc., PGEN Therapeutics, Inc. develops gene and cellular therapies. The private company is based in Henrico, MD. | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Helen Sabzevari
- Expérience
